Factors affecting the production of nanostructure lipid carriers of valproic acid

Journal of Biomedical Nanotechnology

Volumn 9, Issue 2, 2013, Pages 202-212

  Varshosaz, Jaleh ^a   Eskandari, Sharareh ^a   Kennedy, Ross ^b   Tabbakhian, Majid ^a   Minaiyan, Mohsen ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Box Behnken; Desirability Function; Nano Lipid Carrier; Valproic Acid

Indexed keywords

BOX-BEHNKEN; DESIRABILITY FUNCTION; NANO-LIPID CARRIER; NANOSTRUCTURE LIPID CARRIERS; OPTIMUM FORMULATION; SOLVENT DIFFUSION METHODS; SURFACTANT CONCENTRATIONS; VALPROIC ACID;

PARTICLE SIZE; SURFACE ACTIVE AGENTS;

OPTIMIZATION;

NANOMATERIAL; POLOXAMER; VALPROIC ACID;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; IN VITRO STUDY; NANOEMULSION; PARTICLE SIZE; PHYSICAL CHEMISTRY; RESPONSE SURFACE METHOD;

DRUG CARRIERS; LIPIDS; MICROSCOPY, ATOMIC FORCE; MODELS, THEORETICAL; NANOSTRUCTURES; PARTICLE SIZE; REGRESSION ANALYSIS; SURFACE-ACTIVE AGENTS; VALPROIC ACID;

EID: 84876512093     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1484     Document Type: Article

References (27)

1. R. H. Müller, M. Radtke, and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Del. Rev. 54, S131 (2002).
2. C. W. Pouton, Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. 11, S93 (2000).
3. R. H. Müller, Lipid nanoparticles: Recent advances. Adv. Drug Del. Rev. 59, 375 (2007).
4. K. Joresa, W. Mehnerta, M. Drechslerb, H. Bunjesc, C. Johannd, and K. Mader, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Rel. 95, 217 (2004).
5. S. Baltes, H. Potschka, C. L. Tortos, M. Fedrowitz, and W. Loscher, Valproaic acid is not a substrate for P-glycoprotein or multidrug resistance proteins MRP1 and MRP2 in a number of in vitro and in vivo transport assays. J. Pharmacol. Exp. Ther. 320, 331 (2007).
6. R. S. Fisher and J. Ho, Potential new methods for antiepileptic drug delivery. CNS. Drugs 16, 579 (2002).
7. J. M. Barichello, M. Morishita, K. Takayama, and T. Nagai, Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug. Dev. Ind. Pharm. 25, 471 (1999).
8. E. Garcia-Garcia, K. Andrieux, S. Gilb, and P. Couvreur, Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? Int. J. Pharm. 298, 274 (2005).
9. H. Yuan, L. L. Wang, Y. Z. Du, J. You, F. Q. Hu, and S. Zeng, Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloid. Surf. B 60, 174 (2007).
10. S. L. C. Ferreira, R. E. Bruns, H. S. Ferreira, G. D. Matos, J. M. David, G. C. Brandao, E. G. P. da Silva, L. A. Portugal, P. S. dos Reis, A. S. Souza, and W. N. L. dos Santos, Box-Behnken design: An alternative for the optimization of analytical methods. Analytica. Chimica. Acta 597, 179 (2007).
11. J. Varshosaz, S. Eskandari, and M. Tabbakhian, Production and optimization of valproic acid in nanostructured lipid carriers by the taguchi design. Pharm. Dev. Tech. 15, 89 (2010).
12. G. E. P. Box and D. W. Behnken, Some new three level designs for the study of quantitative variables. Technometrics 2, 455 (1960).
13. A. S. Zidan, O. A. Sammour, M. A. Hammad, N. A. Megrab, M. J. Habib, and M. A. Khan, Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by box-behnken design and desirability function. Int. J. Pharm. 332, 55 (2007).
14. E. C. Harrington, The desirability function. Ind. Qual. Cont. 21, 494 (1965).
15. G. Derringer and R. Suich, Simultaneous optimization of several response variables. I. Qual. Technol. 12, 214 (1980).
16. V. Heydenreich, R. Westmeier, N. Pedersen, H. S. Poulsen, and H. G. Kristensen, Preparation and purification of cationic solid lipid nanospheres-effect on particle size, physical stability and cell toxicity. Int. J. Pharm. 254, 83 (2003).
17. P. Kishore, V. Rajani Kumar, V. Satyanarayana, and D. R. Krishna, HPLC determination of valproic acid in human serum. Pharmazie 58, 378 (2003).
18. J. Engel, T. A. Pedley, and J. Aicardi, Epilepsy a Comprehensive Text Book, Lippincott Reverend and Wilkins, Philadelphia (2007).
19. S. Chopra, G. V. Patil, and S. K. Motwani, Release modulation hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design. Eur. J. Pharm. Biopharm. 66, 73 (2007).
20. D. Douroumis and A. Fahr, Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique. Eur. J. Pharm. Biopharm. 63, 173 (2006).
21. Z. Muhlen, C. Schwarz, and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism. Eur. J. Pharm. Biopharm. 45, 149 (1998).
22. C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterization. J. Microencapsul. 16, 205 (1999).
23. V. B. Patravale and A. V. Ambarkhane, Study of solid lipid nanoparticles with respect to particle size distribution and drug loading. Pharmazie 58, 392 (2003).
24. J. Varshosaz, S. Ghaffari, M. R. Khoshayand, F. Atyabi, S. Azarmi, and F. Kobarfard, Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J. Liposome Res. 20, 97 (2010).
25. B. Ruozi, G. Tosi, F. Forni, M. Fresta, and M. A. Vandelli, Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes. Eur. J. Pharm. Sci. 25, 81 (2005).
26. M. Hamidi, P. Rafiei, A. Azadi, and S. Mohammadi-Samani, Encapsulation of valproate-oaded hydrogel nanoparticles in intact human erythrocytes: A novel nano-cell composite for drug delivery. J. Pharm. Sci. 100, 1702 (2011).
27. N. R. Draper and H. Smith, Applied Regression Analysis, John Wiley and Sons, Inc., New York (1998).